Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions.
Conference Paper
Posttraumatic stress disorder (PTSD) has long been recognized as responsive to drug and somatic treatments. Clinical characteristics and patterns of treatment response were well described in the 1940s. Recent studies indicate that tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) have specific ameliorative effects on PTSD symptoms, but further work is needed in this regard. Goals of drug therapy are provided and future directions suggested.
Full Text
Duke Authors
Cited Authors
- Davidson, JR; Nemeroff, CB
Published Date
- 1989
Published In
Volume / Issue
- 25 / 3
Start / End Page
- 422 - 425
PubMed ID
- 2697012
International Standard Serial Number (ISSN)
- 0048-5764
Conference Location
- United States